Form 4: ASP Isotopes COO Robert Ainscow Sells Shares Under 10b5-1 Trading Plan

Robert Ainscow, Chief Operating Officer of ASP Isotopes Inc., executed sales of common stock between April 15 and April 17, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Robert Ainscow, the Chief Operating Officer of ASP Isotopes Inc., sold shares of common stock over three days in April 2025.
• The sales were conducted under a Rule 10b5-1 trading plan adopted on December 13, 2024.
• On April 15, 2025, 66,666 shares were sold at a weighted average price of $5.7535, with individual prices ranging from $5.48 to $6.70.
• On April 16, 2025, another 66,666 shares were sold at a weighted average price of $5.4454, with individual prices ranging from $5.26 to $5.70.
• On April 17, 2025, 66,668 shares were sold at a weighted average price of $5.6213, with individual prices ranging from $5.25 to $6.02.
• Following these transactions, Ainscow directly owns 1,419,992 shares of ASP Isotopes Inc.
• The sales were executed to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: The sentiment is neutral as the stock sales were conducted under a pre-arranged trading plan. It doesn't necessarily indicate a positive or negative outlook on the company's future.

Risks

• Executive stock sales can sometimes be perceived negatively by investors, potentially impacting the stock price.

Industry Context

Insider sales are a common occurrence, and the use of 10b5-1 plans allows insiders to sell shares without being accused of trading on material non-public information. Investors often monitor insider transactions for signals about a company's prospects.

Stakeholder Impact

• Shareholders may react to the news of insider selling, potentially impacting the stock price in the short term.

Key Dates

Keywords

ASP Isotopes, Robert Ainscow, Form 4, insider trading, Rule 10b5-1, stock sales, ASPI, COO